摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-溴苯硼酸频呐醇酯 | 594823-67-3

中文名称
3-溴苯硼酸频呐醇酯
中文别名
3-溴苯硼酸频那醇酯
英文名称
2-(3-bromophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
英文别名
3-bromophenylboronic acid pinacol ester
3-溴苯硼酸频呐醇酯化学式
CAS
594823-67-3
化学式
C12H16BBrO2
mdl
——
分子量
282.973
InChiKey
FHCWGLQDAMYXJS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    48 °C
  • 沸点:
    333.2±25.0 °C(Predicted)
  • 密度:
    1.29±0.1 g/cm3(Predicted)
  • 溶解度:
    溶于甲醇

计算性质

  • 辛醇/水分配系数(LogP):
    2.75
  • 重原子数:
    16
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    18.5
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2934999090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    2-8°C

SDS

SDS:c5bcb643aea97451ae0912175d337e74
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 3-Bromophenylboronic acid, pinacol ester
Synonyms: 3-Bromo-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-yl)benzene

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 3-Bromophenylboronic acid, pinacol ester
CAS number: 594823-67-3

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C12H16BBrO2
Molecular weight: 283.0

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

制备3-(4,4,5,5-四甲基-1,3,2-二氧杂环戊硼烷-2-基)溴苯:将4.24 mmol的间二溴苯、4.24 mmol的联硼酸频那醇酯、0.212 mmol 1,1'-双(二苯基膦)二茂铁二氯化钯二氯甲烷络合物、600 mg醋酸钾和20 mL 1,4-二氧六环加入到双口反应瓶中。在双排管上抽真空-充氮气-再抽真空,循环三次后用氮气保护反应体系,在85℃下回流反应10小时后停止反应。使用旋转蒸发仪除去溶剂,通过柱层析分离得到白色固体。

制得的中间产物1(3-(4,4,5,5-四甲基-1,3,2-二氧杂环戊硼烷-2-基)溴苯)经1H NMR验证,结果表明结构正确。1H NMR (400 MHz, CDCl₃) δ (ppm) = 7.93(s, 1H), 7.71(d, J=7.6 Hz, 1H), 7.58(ddd, J=8.0, 2.0, 1.2 Hz, 1H), 7.23(t, J=7.6 Hz, 1H), 1.34(s, 12H)。

3-溴苯硼酸频那醇酯可用于合成一种绿光铱(III)配合物,该配合物具有较高的发光效率。它含有特殊的功能基团——电子传输性能的氟苯基团,有利于载流子在复合区域的传输平衡,从而使得有机电致发光器件表现出优异的性能。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-溴苯硼酸频呐醇酯 在 gold(III) chloride 、 N-溴代丁二酰亚胺(NBS) 作用下, 以 1,2-二氯乙烷 为溶剂, 反应 24.0h, 以83%的产率得到2,5-二溴苯硼酸频哪醇酯
    参考文献:
    名称:
    金(III)芳香族硼酸酯的催化的卤化与Ñ -Halosuccinimides
    摘要:
    芳环上带有卤素取代基的芳族硼酸酯可通过AuCl 3催化的N-卤代琥珀酰亚胺的卤化反应合成。
    DOI:
    10.1021/ol102350v
  • 作为产物:
    参考文献:
    名称:
    N-羟基邻苯二甲酰亚胺酯对异烟酸酯的催化(杂)芳基和烯基羧酸的脱羧硼化反应
    摘要:
    芳基和链烯基羧酸与双(频哪醇合)二硼的脱羧硼化通过实现Ñ使用-hydroxyphthalimide酯叔异烟酸丁酯在无碱条件下作为催化剂。可以将具有不同官能团和电子特性的各种芳基羧酸平稳地转化为芳基硼酸酯,包括在过渡金属催化下难以脱羧的芳基硼酸酯,从而提供了一种新方法,使羧酸可以用作有机合成中的基础。机理分析表明,该反应通过自由基脱羧产生的瞬态芳基与吡啶稳定的持久性硼基的偶联而进行。氧化还原活性酯的活化可以通过分子内单电子转移(SET)过程,通过吡啶-二硼-邻苯二甲酰亚胺加合物进行,并说明了无碱反应条件。
    DOI:
    10.1021/acs.orglett.7b01950
点击查看最新优质反应信息

文献信息

  • Redox-Neutral Borylation of Aryl Sulfonium Salts via C–S Activation Enabled by Light
    作者:Chen Huang、Jie Feng、Rui Ma、Shuaishuai Fang、Tao Lu、Weifang Tang、Ding Du、Jian Gao
    DOI:10.1021/acs.orglett.9b03850
    日期:2019.12.6
    photoinduced strategy for the borylation of aryl sulfonium salts using bis(pinacolato)diboron as the boron source. This method exploits redox-neutral aryl sulfoniums to gain access to aryl radicals via C-S bond activation upon photoexcitation under transition-metal-free conditions. Therefore, it grants access to diverse arylboronate esters with good performance from easily available aryl sulfoniums accompanied
    本文报道了一种使用双(频哪醇)二硼作为硼源进行芳基sulf盐的硼化的新光诱导策略。该方法利用氧化还原中性芳基sulf在无过渡金属条件下进行光激发时通过CS键活化来获得芳基自由基。因此,它可从容易获得的芳基sulf获得具有良好性能的各种芳基硼酸酯,并伴有温和的条件,操作简便和易于扩展。
  • Synthesis of Pinacol Arylboronates from Aromatic Amines: A Metal-Free Transformation
    作者:Di Qiu、Liang Jin、Zhitong Zheng、He Meng、Fanyang Mo、Xi Wang、Yan Zhang、Jianbo Wang
    DOI:10.1021/jo3018878
    日期:2013.3.1
    A metal-free borylation process based on Sandmeyer-type transformation using arylamines derivatives as the substrates has been developed. Through optimization of the reaction conditions, this novel conversion can be successfully applied to a wide range of aromatic amines, affording borylation products in moderate to good yields. Various functionalized arylboronates, which are difficult to access by
    基于芳基胺衍生物作为底物的基于Sandmeyer型转化的无金属硼化工艺已得到开发。通过优化反应条件,这种新颖的转化方法可以成功地应用于各种芳族胺,从而以中等至良好的收率获得硼酸酯化产物。通过这种无金属的转化,可以容易地获得各种难以通过其他方法获得的官能化的芳基硼酸酯。此外,在不纯化硼酸酯化产物的情况下,Suzuki-Miyaura交叉偶联后即可进行这种转化,从而增强了该方法的实用性。已经提出了可能的涉及自由基物质的反应机理。
  • [EN] SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE<br/>[FR] INHIBITEURS À PETITE MOLÉCULE DE KINASE INDUISANT NF-KB
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2020239999A1
    公开(公告)日:2020-12-03
    The present invention relates to compounds that inhibit NIK and pharmaceutical compositions comprising such compounds and methods of using the same. These compounds and pharmaceutical compositions are envisaged to be useful for preventing or treating diseases such as cancer (such as B-cell malignancies including leukemias, lymphomas and myeloma), inflammatory disorders, autoimmune disorders, immunodermatologic disorders such as palmoplantar pustulosis and hidradenitis suppurativa, and metabolic disorders such as obesity and diabetes.
    本发明涉及抑制NIK的化合物,以及包含这些化合物的药物组合物和使用方法。这些化合物和药物组合物预期能用于预防或治疗癌症(如包括白血病、淋巴瘤和多发性骨髓瘤的B细胞恶性肿瘤)、炎症性疾病、自身免疫疾病、免疫皮肤病学疾病(如掌跖脓疱病和化脓性汗腺炎)以及代谢紊乱疾病(如肥胖和糖尿病)。
  • [EN] EZH2 INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE EZH2 ET LEURS UTILISATIONS
    申请人:PIRAMAL ENTPR LTD
    公开号:WO2015110999A1
    公开(公告)日:2015-07-30
    The present invention provides compound of formula 1, or an isotopic form, a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a solvate, a polymorph, a prodrug, S-oxide or N-oxide thereof. The invention also relates toprocesses for their preparation, to pharmaceutical compositions containing them and use of the compound of formula 1, in the treatment of diseases or disorders mediated by EZH2 (enhancer of zeste homolog 2), particularly cancer.
    本发明提供了式1的化合物,或其同位素形式、立体异构体、互变异构体、药学上可接受的盐、溶剂合物、多晶形态、前药、其S-氧化物或N-氧化物。该发明还涉及它们的制备方法,含有它们的药物组合物以及利用式1的化合物治疗由EZH2(增强子齐斯特同源物2)介导的疾病或紊乱。
  • Merging Halogen-Atom Transfer (XAT) and Copper Catalysis for the Modular Suzuki–Miyaura-Type Cross-Coupling of Alkyl Iodides and Organoborons
    作者:Zhenhua Zhang、Bartosz Górski、Daniele Leonori
    DOI:10.1021/jacs.1c12649
    日期:2022.2.2
    Suzuki–Miyaura-type cross-couplings between alkyl iodides and aryl organoborons. This process requires a copper catalyst but, in contrast with previous approaches based on palladium and nickel systems, does not utilizes the metal for the activation of the alkyl electrophile. Instead, this strategy exploits the halogen-atom-transfer ability of α-aminoalkyl radicals to convert secondary alkyl iodides into the
    我们在这里报告了一种机制上不同的方法来实现烷基碘和芳基有机硼之间的 Suzuki-Miyaura 型交叉偶联。该过程需要铜催化剂,但与以前基于钯和镍系统的方法相比,它不使用金属来活化烷基亲电试剂。相反,该策略利用 α-氨基烷基自由基的卤素原子转移能力将仲烷基碘转化为相应的烷基自由基,然后与芳基、乙烯基、炔基、苄基和硼酸烯丙酯物质偶联。这些新颖的偶联反应具有简单的设置和条件(室温下 1 小时),并有助于获得制药行业所针对的特权基序。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐